The Use of Roxifiban (DMP754), a Novel Oral Platelet Glycoprotein IIb/IIIa Receptor Inhibitor, in Patients with Stable Coronary Artery Disease

Author： Murphy J.

Publisher： Adis International

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.3, Iss.2, 2003-01, pp. : 101-112

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Optimal Use of Platelet Glycoprotein IIb/IIIa Receptor Antagonists in Patients Undergoing Percutaneous Coronary Interventions

By Starnes H. Benjamin Patel Ankit A. Stouffer George A.

Drugs, Vol. 71, Iss. 15, 2011-10 ,pp. : 2009-2030

Adis International

Access to resources Recommend Favorite

Platelet Glycoprotein IIb/IIIa Receptor Antagonists And Their Use In Elderly Patients

By Mak K-H.

Drugs & Aging, Vol. 16, Iss. 3, 2000-03 ,pp. : 179-187

Adis International

Access to resources Recommend Favorite

Platelet Glycoprotein IIb/IIIa Polymorphism and Coronary Artery Disease: Implications for Clinical Practice

By Augusto Di Castelnuovo Giovanni de Gaetano Maria Benedetta Donati Iacoviello Licia

American Journal of PharmacoGenomics, Vol. 5, Iss. 2, 2005-01 ,pp. : 93-99

Adis International

Access to resources Recommend Favorite

Platelet glycoprotein IIb/IIIa antagonists in clinical trials for the treatment of coronary artery disease

By Salam Amar M Al Suwaidi Jassim

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 11, 2002-11 ,pp. : 1645-1658

Informa Healthcare

Access to resources Recommend Favorite

Eptifibatide: a potent inhibitor of the platelet receptor integrin glycoprotein IIb/IIIa

By Tcheng James E O’Shea J Conor

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 8, 2002-08 ,pp. : 1199-1210

Informa Healthcare

Access to resources Recommend Favorite